Caregivers’ Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study

References

• Ashford, R., A. McNeill Brown, T. Brown, and J. Whitney. 2019. Defining and operationalizing the phenomena of recovery: A working definition from the recovery science research collaborative. Addiction Research & Theory 27 (3):179–88. doi:10.1080/16066359.2018.1515352.
   Web of Science ®Google Scholar
• Blanco, C., and N. D. Volkow. 2019. Management of opioid use disorder in the USA: Present status and future directions. The Lancet 393 (10182):1760–72. doi:10.1016/S0140-6736(18)33078-2.
   PubMed Web of Science ®Google Scholar
• Chai, D., T. Rosic, B. Panesar, N. Sanger, E. A. van Reekum, D. C. Marsh, A. Worster, L. Thabane, and Z. Samaan. 2021. Patient-reported goals of youths in Canada receiving medication-assisted treatment for opioid use disorder. JAMA Network 4 (8):e2119600. doi:10.1001/jamanetworkopen.2021.19600.
   PubMed Web of Science ®Google Scholar
• Cioe, K., B. E. Biondi, R. Easly, A. Simard, X. Zheng, and S. A. Springer. 2020. A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment 119:108146. doi:10.1016/j.jsat.2020.108146.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., F. Charlson, B. Mathers, W. D. Hall, A. D. Flaxman, N. Johns, and T. Vos. 2014. The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study. Addiction 109 (8):1320–33. doi:10.1111/add.12551.
   PubMed Web of Science ®Google Scholar
• De Maeyer, J., W. Vanderplasschen, L. Camfield, S. Vanheule, B. Sabbe, and E. Broekaert. 2011. A good quality of life under the influence of methadone: A qualitative study among opiate-dependent individuals. International Journal of Nursing Studies 48 (10):1244–57. doi:10.1016/j.ijnurstu.2011.03.009.
   PubMed Web of Science ®Google Scholar
• Dickson-Gomez, J., A. Spector, M. Weeks, C. Galletly, M. McDonald, and H. D. Green Montaque. 2022. “You’re not supposed to be on it forever”: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Substance Abuse: Research and Treatment 16:11782218221103859. doi:10.1177/11782218221103859.
   Web of Science ®Google Scholar
• Dole, V. P., and M. Nyswander. 1965. A medical treatment for diacetylmorphine (Heroin) addiction. a clinical trial with methadone hydrochloride. JAMA 193 (8):646–50. doi:10.1001/jama.1965.03090080008002.
   PubMed Web of Science ®Google Scholar
• European Drug Report 2018: Trends and Developments European drug report. 2018. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
   Google Scholar
• Gronbladh, L., and L. Gunne. 1989. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug and Alcohol Dependence 24 (1):31–37. doi:10.1016/0376-8716(89)90005-7.
   PubMed Web of Science ®Google Scholar
• Gronnestad, T. E., and H. Sagvaag. 2016. Stuck in limbo: Illicit drug users’ experiences with opioid maintenance treatment and the relation to recovery. International Journal of Qualitative Studies on Health and Well-Being 11 (1):31992. doi:10.3402/qhw.v11.31992.
   PubMed Web of Science ®Google Scholar
• Guest, G., A. Bunce, and L. Johnson. 2006. How many interviews are enough? An experiment with data saturation and variability. Field Methods 18 (1):59–82. doi:10.1177/1525822X05279903.
   Web of Science ®Google Scholar
• Guest, G., K. MacQueen, and E. Namey. 2012. Applied Thematic Analysis. London: Sage Publications. doi:10.4135/9781483384436.
   Google Scholar
• Gutwinski, S., L. K. Bald, J. Gallinat, A. Heinz, and F. Bermpohl. 2014. Why do patients stay in opioid maintenance treatment? Substance Use & Misuse 49 (6):694–99. doi:10.3109/10826084.2013.863344.
   PubMed Web of Science ®Google Scholar
• Läkemedelsassisterad behandling vid opioidberoende. 2020. (Medication-assisted treatment for opioid use disorder): National board of health and welfare.
   Google Scholar
• Malterud, K., V. D. Siersma, and A. D. Guassora. 2016. Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research 26 (13):1753–60. doi:10.1177/1049732315617444.
   PubMed Web of Science ®Google Scholar
• Marchand, K., and E. Oviedo-Joekes. 2017. Prioritizing the patient in patient-centered addictions treatment. Addiction 112 (3):466–67. doi:10.1111/add.13680.
   PubMed Web of Science ®Google Scholar
• Marshall, K., G. Maina, and J. Sherstobitoff. 2021. Plausibility of patient-centred care in high-intensity methadone treatment: Reflections of providers and patients. Addiction Science & Clinical Practice 16 (1):42. doi:10.1186/s13722-021-00251-9.
   PubMed Web of Science ®Google Scholar
• Mattick, R., C. Breen, J. Kimber, and M. Davoli. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002209.pub2.
   PubMed Web of Science ®Google Scholar
• Morgan, J. R., B. R. Schackman, J. A. Leff, B. P. Linas, and A. Y. Walley. 2018. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. Journal of Substance Abuse Treatment 85:90–96. doi:10.1016/j.jsat.2017.07.001.
   PubMed Web of Science ®Google Scholar
• Nationella riktlinjer för missbruks- och beroendevård (National guidelines for addiction treatment). 2019. National board of health and welfare Sweden.
   Google Scholar
• Nehlin, C., J. Backstrom, C. W. Brander, and C. Oster. 2022. Patients’ perspectives on coming off opioid agonist treatment: A qualitative study. Substance Abuse: Research and Treatment 16:11782218221107021. doi:10.1177/11782218221107021.
   Web of Science ®Google Scholar
• Noble, F., and N. Marie. 2018. Management of Opioid Addiction with Opioid Substitution Treatments: Beyond Methadone and Buprenorphine. Frontiers in Psychiatry / Frontiers Research Foundation 9:742. doi:10.3389/fpsyt.2018.00742.
   PubMed Web of Science ®Google Scholar
• Notley, C., A. Blyth, V. Maskrey, J. Craig, and R. Holland. 2013. The experience of long-term opiate maintenance treatment and reported barriers to recovery: A qualitative systematic review. European Addiction Research 19 (6):287–98. doi:10.1159/000346674.
   PubMed Web of Science ®Google Scholar
• Novak, S., A. Håkansson, J. Martinez-Raga, J. Reimer, K. Krothki, and S. Varughese. 2016. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry 16 (1):274. doi:10.1186/s12888-016-0909-3.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, M., and S. Murphy. 1984. Always a junkie? The ardous task of getting off methadone maintenance. Journal of Drug Issues 1984 (3):527–52. doi:10.1177/002204268401400307.
   Google Scholar
• Santo, T., Jr., B. Clark, M. Hickman, J. Grebely, G. Campbell, L. Sordo, A. Chen, L. T. Tran, C. Bharat, P. Padmanathan, et al. 2021. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis. JAMA Psychiatry 78 (9):979–93. doi:10.1001/jamapsychiatry.2021.0976.
   PubMed Web of Science ®Google Scholar
• Sordo, L., G. Barrio, M. J. Bravo, B. I. Indave, L. Degenhardt, L. Wiessing, M. Ferri, and R. Pastor-Barriuso. 2017. Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ 357:j1550. doi:10.1136/bmj.j1550.
   PubMed Web of Science ®Google Scholar
• Stein, M. D., M. T. Conti, D. S. Herman, B. J. Anderson, G. L. Bailey, D. V. Noppen, and A. M. Abrantes. 2019. Worries about discontinuing buprenorphine treatment: Scale development and clinical correlates. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism & Addictions 28 (4):270–76. doi:10.1111/ajad.12884.
   PubMed Web of Science ®Google Scholar
• Strike, C. J., and A. Guta. 2017. Patient-centred care and patient engagement to inform the use of psychosocial interventions with opioid substitution treatment: Another path for Day & Mitcheson to follow. Addiction 112 (8):1338–39. doi:10.1111/add.13708.
   PubMed Web of Science ®Google Scholar
• Williams, A. R., E. V. Nunes, A. Bisaga, H. A. Pincus, K. A. Johnson, A. N. Campbell, R. H. Remien, S. Crystal, P. D. Friedmann, F. R. Levin, et al. 2018. Developing an opioid use disorder treatment cascade: A review of quality measures. Journal of Substance Abuse Treatment 91:57–68. doi:10.1016/j.jsat.2018.06.001.
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., N. Lintzeris, and T. Lea. 2011. “Should I stay or should I go?” Coming off methadone and buprenorphine treatment. The International Journal on Drug Policy 22 (1):77–81. doi:10.1016/j.drugpo.2010.08.001.
   PubMed Web of Science ®Google Scholar
• Zweben, J. E., J. L. Sorensen, M. Shingle, and C. K. Blazes. 2021. Discontinuing methadone and buprenorphine: A review and clinical challenges. Journal of Addiction Medicine 15 (6):454–60. doi:10.1097/ADM.0000000000000789.
   PubMed Web of Science ®Google Scholar